Have a personal or library account? Click to login
Growing Challenges of Lung Infections with Non-tuberculous Mycobacteria in Immunocompromised Patients: Epidemiology and Treatment Cover

Growing Challenges of Lung Infections with Non-tuberculous Mycobacteria in Immunocompromised Patients: Epidemiology and Treatment

Archivum Immunologiae et Therapiae Experimentalis
Volume 73 (2025): Issue 1 (January 2025)
By: Weronika Burzyńska,  Marek Fol and  Magdalena Druszczynska  
Open Access
|Mar 2025

Authors

Weronika Burzyńska

Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland

Marek Fol

Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland

Magdalena Druszczynska

magdalena.druszczynska@biol.uni.lodz.pl

Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland
DOI: https://doi.org/10.2478/aite-2025-0005 | Journal eISSN: 1661-4917
Journal RSS Feed
Language: English
Submitted on: Oct 28, 2024
|
Accepted on: Jan 14, 2025
|
Published on: Mar 14, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Non-tuberculous mycobacteria,
Lung infections,
Immunodeficiency,
atypical mycobacteria
Related subjects:
Medicine,
Basic medical science,
Biochemistry,
Immunology,
Clinical medicine,
Clinical medicine, other,
Clinical chemistry

© 2025 Weronika Burzyńska, Marek Fol, Magdalena Druszczynska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2025): Issue 1 (January 2025)Next article